Hims & Hers Health's plan to enter the business of selling peptides is looking a lot more realistic after the FDA announced it plans to hold a pair of meetings this summer to decide whether to loosen restrictions on certain peptides. Our proprietary real time alert services picked up HIMS's unusual stock and option volume early Wednesday morning. Depending on your favorite momentum indicator several opportunities presented themselves to get in to capture a portion of the dai

Hims & Hers Health, the leading health and wellness platform, announced its plans to introduce at-home lab testing through its platform....

Hims & Hers Health shares rose early last week after regulators said they would reconsider their decision that would have put limits on...